The medical devices sector is typified by frequent change and innovation, in response to problems and issues faced by the healthcare industry. As a result, the sector has seen the emergence of several start-up medtech companies offering disruptive, cutting-edge solutions. Most of these are private companies, where data such as revenue is frequently not disclosed. National estimates for UTAK Laboratories sales in the US from 2017 to 2023, as well as year-on-year growth rates, can be viewed in GlobalData’s micro revenue report. Buy the report here.
Smarter leaders trust GlobalData
UTAK Laboratories Inc (UTAK) is a quality control provider for the in-vitro diagnostic testing industry. The company’s products include starting QC, stock QC and personalized QC. Its starting QC products include matrix and specialty matrix. UTAK’s stock QC products include matrix and control classes. The company products also include adulteration controls, serum control, oral fluid control, urine control and whole blood control, among others. Its Serum Control products comprise benzodiazepines, clonazepam, defibrinated plasma, DHEA plus, meprobamate, methotrexate, methylmalonic acid, mycophenolic acid, normal serum, pentobarbital and SSRI plus. UTAK’s custom products also operate in clinical, forensic, and environmental applications. The company operates products in South Africa, Canada, the Philippines, Thailand, Taiwan, Australia, and others. UTAK is headquartered in Valencia, California, the US.
The key metrics of UTAK Laboratories related to marketed and pipeline products, ongoing clinical trials, active jobs and publications from 2023 are shown below:
As UTAK Laboratories is a privately held company, it is not required to disclose its financial information and there is no stock listed on an exchange. GlobalData has access to a proprietary data set containing invoice data from over 2,600 healthcare institutions in the US and is therefore able to use estimations of a company’s revenue and growth to value private companies such as UTAK Laboratories.
For a detailed understanding of the performance of UTAK Laboratories, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData’s revenue report leverages GlobalData’s SKU tracker, which contains real-world, purchasing data from the US healthcare institutions.
